4-amino-5-hexynoic acid has been researched along with Parkinson Disease, Secondary in 1 studies
4-amino-5-hexynoic acid: structure
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casey, DE | 1 |
| Gerlach, J | 1 |
| Magelund, G | 1 |
| Christensen, TR | 1 |
1 trial available for 4-amino-5-hexynoic acid and Parkinson Disease, Secondary
| Article | Year |
|---|---|
gamma-Acetylenic GABA in tardive dyskinesia.
Topics: 4-Aminobutyrate Transaminase; Adult; Aged; Alkynes; Aminocaproates; Antipsychotic Agents; Brain; Dop | 1980 |